The Venus Times

Venus Remedies Ltd. recently received Marketing Authorization (MA) to market our generic antibiotic, Meropenem, in Spain. This significant achievement marks a major milestone for the organization and reinforces our commitment to providing high-quality healthcare solutions globally. The approval from the Spanish regulator is a testament to the rigorous research, development,

Venus Remedies, a leading pharmaceutical company dedicated to improving global healthcare, has achieved yet another milestone. We have recently received the prestigious Good Manufacturing Practice (GMP) approval from Ukraine for our state-of-the-art Carbapenem and Oncology Parenteral facilities at our unit in Baddi. The GMP certification is a testament to our

Venus Remedies has received Good Manufacturing Practices (GMP) certification from the Kenya Pharmacy and Poisons Board for all its production facilities located in Baddi, Himachal Pradesh. This certification recognizes Venus Remedies' commitment to maintaining high-quality standards in manufacturing pharmaceutical products. The GMP certification is a crucial milestone for Venus as

Venus Remedies has recently achieved a significant milestone by obtaining marketing authorizations for two of its groundbreaking cancer drugs in Iraq and Philippines. This recent development not only underscores the company's commitment to improving global healthcare but also highlights its growing presence in the Middle East. Venus Remedies has long

Thrilled to share a remarkable achievement by Venus Remedies, as it proudly expands its global footprint in the field of oncology. With a recent contract win in Ukraine, Venus Remedies has taken a significant step towards combating cancer in a nation ravaged by war. This momentous occasion signifies our commitment

Venus Pharma GmbH, the German subsidiary of Venus Remedies Limited, has recently received a Marketing Authorization (MA) certificate from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for its chemotherapy drug, Cisplatin. The company has been granted the license to market this drug in three different strengths: 10mg-10ml, 50mg-50ml,

Venus Remedies Limited has been granted a representative office license in Vietnam, expanding our reach and allowing us to provide even more comprehensive healthcare solutions to patients in the region. Venus Remedies Limited is a leading pharmaceutical company committed to providing innovative and high-quality healthcare solutions to people worldwide. With

The Barbados Drug Service has approved Venus Remedies Limited products for use in the country, marking a significant step forward in our commitment to providing innovative and high-quality healthcare solutions worldwide. The Barbados Drug Service is a government agency responsible for regulating and providing access to essential drugs and healthcare

Venus recently received Good Manufacturing Practices (GMP) Certification from Saudi Arabia for all its production facilities at its Baddi, Himachal Pradesh unit, thus taking the organization's total global GMP certifications to 20. The Saudi Food and Drug Authority (SFDA) while granting this certification also renewed the approval for Cephalosporin and

Venus has been working on target-based drug delivery for cancer treatment and diagnostics. The company has recently received marketing authorizations for its cancer drugs from Uzbekistan and Palestine. It has received marketing approval for Carboplatin in Uzbekistan and Docetaxel and Irinotecan in Palestine. With over 800 marketing authorizations worldwide, this